Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11821008rdf:typepubmed:Citationlld:pubmed
pubmed-article:11821008lifeskim:mentionsumls-concept:C0005854lld:lifeskim
pubmed-article:11821008lifeskim:mentionsumls-concept:C0178539lld:lifeskim
pubmed-article:11821008lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:11821008lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:11821008lifeskim:mentionsumls-concept:C0332453lld:lifeskim
pubmed-article:11821008pubmed:issue2lld:pubmed
pubmed-article:11821008pubmed:dateCreated2002-1-31lld:pubmed
pubmed-article:11821008pubmed:abstractTextThe first goal of the present study was to determine the effect of tumor necrosis factor-alpha (TNF-alpha) on the permeability of the blood-brain barrier in vivo. The second goal of this study was to investigate cellular pathways responsible for changes in permeability of the blood-brain barrier in response to TNF-alpha. We examined the pial microcirculation in rats using intravital fluorescence microscopy. Permeability of the blood-brain barrier was quantitated by calculating the clearance of fluorescent-labeled dextran (mol. wt=10,000; FITC-dextran-10K) during superfusion with vehicle, tumor necrosis factor (TNF-alpha; 10 ng/ml), TNF-alpha in the presence of an inhibitor of soluble guanylate cyclase (ODQ; 1.0 microM), and TNF-alpha in the presence of an inhibitor of protein tyrosine kinase (genistein; 10 microM). During superfusion with vehicle, clearance of FITC-dextran-10K from pial vessels remained relatively constant during the experimental period. In contrast, superfusion with TNF-alpha markedly increased clearance of FITC-dextran-10K from the cerebral microcirculation. Topical application of ODQ and genistein, significantly inhibited increases in permeability of the blood-brain barrier to FITC-dextran-10K during application of TNF-alpha. Thus, TNF-alpha increases the permeability of the blood-brain barrier to a moderately sized molecule via a mechanism which appears to involve activation of soluble guanylate cyclase and protein tyrosine kinase. In light of evidence suggesting that TNF-alpha production is increased during cerebrovascular trauma, we suggest that the findings of this study may contribute to our understanding of the pathogenesis of disruption of the blood-brain barrier during brain trauma and inflammation.lld:pubmed
pubmed-article:11821008pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11821008pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11821008pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11821008pubmed:languageenglld:pubmed
pubmed-article:11821008pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11821008pubmed:citationSubsetIMlld:pubmed
pubmed-article:11821008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11821008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11821008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11821008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11821008pubmed:statusMEDLINElld:pubmed
pubmed-article:11821008pubmed:monthFeblld:pubmed
pubmed-article:11821008pubmed:issn0006-8993lld:pubmed
pubmed-article:11821008pubmed:authorpubmed-author:MayhanWilliam...lld:pubmed
pubmed-article:11821008pubmed:issnTypePrintlld:pubmed
pubmed-article:11821008pubmed:day15lld:pubmed
pubmed-article:11821008pubmed:volume927lld:pubmed
pubmed-article:11821008pubmed:ownerNLMlld:pubmed
pubmed-article:11821008pubmed:authorsCompleteYlld:pubmed
pubmed-article:11821008pubmed:pagination144-52lld:pubmed
pubmed-article:11821008pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:11821008pubmed:meshHeadingpubmed-meshheading:11821008...lld:pubmed
pubmed-article:11821008pubmed:meshHeadingpubmed-meshheading:11821008...lld:pubmed
pubmed-article:11821008pubmed:meshHeadingpubmed-meshheading:11821008...lld:pubmed
pubmed-article:11821008pubmed:meshHeadingpubmed-meshheading:11821008...lld:pubmed
pubmed-article:11821008pubmed:meshHeadingpubmed-meshheading:11821008...lld:pubmed
pubmed-article:11821008pubmed:meshHeadingpubmed-meshheading:11821008...lld:pubmed
pubmed-article:11821008pubmed:meshHeadingpubmed-meshheading:11821008...lld:pubmed
pubmed-article:11821008pubmed:meshHeadingpubmed-meshheading:11821008...lld:pubmed
pubmed-article:11821008pubmed:meshHeadingpubmed-meshheading:11821008...lld:pubmed
pubmed-article:11821008pubmed:meshHeadingpubmed-meshheading:11821008...lld:pubmed
pubmed-article:11821008pubmed:meshHeadingpubmed-meshheading:11821008...lld:pubmed
pubmed-article:11821008pubmed:meshHeadingpubmed-meshheading:11821008...lld:pubmed
pubmed-article:11821008pubmed:year2002lld:pubmed
pubmed-article:11821008pubmed:articleTitleCellular mechanisms by which tumor necrosis factor-alpha produces disruption of the blood-brain barrier.lld:pubmed
pubmed-article:11821008pubmed:affiliationDepartment of Physiology and Biophysics, University of Nebraska Medical Center, Omaha, NE 68198-4575, USA. wgmayhan@unmc.edulld:pubmed
pubmed-article:11821008pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11821008pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11821008pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11821008lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11821008lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11821008lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11821008lld:pubmed